Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

NCT04823377 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT04823377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04823377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 24, 2021
Completion date
September 23, 2027
Enrollment
364 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, carcinoma, non-small-cell lung